University of Alabama at Birmingham, Birmingham, AL.
Massachusetts General Hospital, Boston, MA.
J Vasc Surg. 2023 Jun;77(6):1578-1587. doi: 10.1016/j.jvs.2023.01.205. Epub 2023 Apr 13.
Spinal cord ischemia (SCI) is a well-known complication of thoracoabdominal aortic aneurysm repair and is associated with profound morbidity and mortality. The purpose of this study was to describe predictors for the development of SCI, as well as outcomes for patients who develop SCI, after branched/fenestrated endovascular aortic repair in a large cohort of centers with adjudicated physician-sponsored investigational device exemption studies.
We used a pooled dataset from nine US Aortic Research Consortium centers involved in investigational device exemption trials for treatment of suprarenal and thoracoabdominal aortic aneurysms. SCI was defined as new transient weakness (paraparesis) or permanent paraplegia after repair without other potential neurological etiologies. Multivariable analysis was performed to identify predictors of SCI, and life-table analysis and Kaplan-Meier methodologies were used to evaluate survival differences.
A total of 1681 patients underwent branched/fenestrated endovascular aortic repair from 2005 to 2020. The overall rate of SCI was 7.1% (3.0% transient and 4.1% permanent). Predictors of SCI on multivariable analysis were Crawford Extent I, II, and III distribution of aortic disease (odds ratio [OR], 4.79; 95% confidence interval [CI], 4.77-4.81; P < .001), age ≥70 years (OR, 1.64; 95% CI, 1.63-1.64; P = .029), packed red blood cell transfusion (OR, 2.00; 95% CI, 1.99-2.00; P = .001), and a history of peripheral vascular disease (OR, 1.65; 95% CI, 1.64-1.65; P = .034). The median survival was significantly worse for patients with any degree of SCI compared with those without SCI (any SCI, 40.4 vs no SCI, 60.3 months; log-rank P < .001), and also worse in those with a permanent deficit (24.1 months) vs those with a transient deficit (62.4 months) (log-rank P < .001). The 1-year survival for patients who developed no SCI was 90.8%, compared with 73.9% in patients who developed any SCI. When stratified by degree of deficit, survival was 84.8% at 1 year for those who developed paraparesis and 66.2% for those who developed permanent deficits.
The overall rates of any SCI at 7.1% and permanent deficit at 4.1% observed in this study compare favorably with those reported in contemporary literature. Our findings confirm that increased length of aortic disease is associated with SCI and those with Crawford Extent I to III thoracoabdominal aortic aneurysms are at highest risk. The long-term impact on patient mortality underscores the importance of preventive measures and rapid implementation of rescue protocols if and when deficits develop.
脊髓缺血(SCI)是胸腹主动脉瘤修复的一种众所周知的并发症,与严重的发病率和死亡率相关。本研究的目的是描述在大量参与经医师发起的调查性器械豁免研究的中心进行分支/开窗血管内主动脉修复后发生 SCI 的预测因素,以及发生 SCI 的患者的结局。
我们使用了来自美国主动脉研究联盟 9 个中心的合并数据集,这些中心参与了治疗肾上和胸腹主动脉瘤的调查性器械豁免试验。SCI 定义为修复后出现新的短暂性无力(截瘫)或永久性截瘫,无其他潜在神经病因。进行多变量分析以确定 SCI 的预测因素,并使用寿命表分析和 Kaplan-Meier 方法评估生存差异。
2005 年至 2020 年期间,共有 1681 例患者接受了分支/开窗血管内主动脉修复。SCI 的总体发生率为 7.1%(3.0%为短暂性,4.1%为永久性)。多变量分析的 SCI 预测因素为 Crawford Ⅰ、Ⅱ和Ⅲ型主动脉疾病分布(比值比[OR],4.79;95%置信区间[CI],4.77-4.81;P<.001)、年龄≥70 岁(OR,1.64;95%CI,1.63-1.64;P=0.029)、输注红细胞(OR,2.00;95%CI,1.99-2.00;P=0.001)和外周血管疾病史(OR,1.65;95%CI,1.64-1.65;P=0.034)。与无 SCI 患者相比,任何程度 SCI 患者的中位生存时间明显更差(任何 SCI,40.4 个月;无 SCI,60.3 个月;对数秩 P<.001),永久性缺陷患者(24.1 个月)比短暂性缺陷患者(62.4 个月)更差(对数秩 P<.001)。无 SCI 患者的 1 年生存率为 90.8%,而发生任何 SCI 的患者为 73.9%。按缺陷程度分层,发生截瘫的患者 1 年生存率为 84.8%,发生永久性缺陷的患者为 66.2%。
本研究中观察到的任何 SCI 总体发生率为 7.1%,永久性缺陷发生率为 4.1%,与当代文献报道的发生率相当。我们的研究结果证实,主动脉疾病的长度增加与 SCI 相关,Crawford Ⅰ至Ⅲ型胸腹主动脉瘤患者风险最高。对患者死亡率的长期影响强调了预防措施的重要性,以及如果出现缺陷时迅速实施抢救方案的重要性。